Andrew Jenkins

Emory University, Atlanta, GA 
GABA receptors, Anesthetic mechanisms, ion channel function
"Andrew Jenkins"
Mean distance: 15.19 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kallay L, Keskin H, Ross A, et al. (2019) Modulating native GABA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death. Journal of Neuro-Oncology
Moody OA, Jenkins A. (2018) The role of loops B and C in determining the potentiation of GABA receptors by midazolam. Pharmacology Research & Perspectives. 6: e00433
Butler KM, Moody OA, Schuler E, et al. (2018) De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain : a Journal of Neurology
Moody OA, Talwar S, Jenkins MA, et al. (2017) Rigor, Reproducibility and in vitro CSF assays: The Devil in the Details. Annals of Neurology
Safavynia SA, Keating G, Spiegel I, et al. (2016) Effects of γ-Aminobutyric Acid Type A Receptor Modulation by Flumazenil on Emergence from General Anesthesia. Anesthesiology
Trotti LM, Saini P, Bliwise DL, et al. (2015) Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. Annals of Neurology
Yuan H, Low CM, Moody OA, et al. (2015) Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Molecular Pharmacology. 88: 203-17
Jenkins MA, Wells G, Bachman J, et al. (2014) Regulation of GluA1 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor function by protein kinase C at serine-818 and threonine-840. Molecular Pharmacology. 85: 618-29
Trotti LM, Saini P, Freeman AA, et al. (2013) Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience. Journal of Psychopharmacology (Oxford, England). 28: 697-702
Rye DB, Bliwise DL, Parker K, et al. (2012) Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Science Translational Medicine. 4: 161ra151
See more...